期刊
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
卷 43, 期 12, 页码 1497-1504出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/00365520802273017
关键词
Chemokine; colitis; innate immunity; macrophage migration inhibitory factor
资金
- Japanese Ministry of Health, Welfare and Labor
- Ministry of Science and Education [18590665]
- National Institute of Biomedical Inovation (NIBIO)
Objective. Macrophage migration inhibitory factor (MIF) plays an important role in the development of inflammatory diseases. Recent studies have indicated an association of MIF with gastrointestinal inflammation including colitis, but the mechanism by which MIF exacerbates gut inflammation has not been fully clarified. In this study, in order further to clarify the role of MIF in intestinal inflammation, we investigated the association of MIF with innate immunity in experimental colitis using MIF-deficient mice. Material and methods. Colitis was induced by treating mice with 3% dextran sulfate sodium (DSS) solution for 7 days. The expressions of chemokines in the colon were determined by reverse transcriptase-polymerase chain reaction (RT-PCR). Myeloperoxidase activity in the colon was measured and immunohistochemistry for F4/80 was analyzed. Results. DSS treatment increased the level of myeloperoxidase activity and infiltration of F4/80-stained cells in the colon, and up-regulated the mRNA expressions in macrophage inflammatory protein (MIP)-1, MIP-2, macrophage chemotaxic protein (MCP)-1, and interferon inducible protein (IP)-10 in wild-type mice. In contrast, this increase and up-regulation were not observed in the colon of MIF-deficient mice treated with DSS. Conclusion. Our findings indicate that a lack of MIF suppresses the innate immune response in DSS-induced colitis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据